Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Citalopram for migraine prophylaxis
IRCT20161103030680N9Phase 3Completed
- Sponsor
- Shahed University
- Start
- Mar 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in migraine comparing Citalopram with Placebo (2 arms). Primary endpoints: Migraine headache intensity, Migraine headache frequency and 3 more. Started Mar 2010; status: completed.
02
Drugs
citalopram
03
Conditions
migraine
Beyond the preview
Go deeper on IRCT20161103030680N9.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20161103030680N9.